On June 25, 2012, MicroPort Shanghai, a wholly-owned subsidiary of MicroPort Scientific Corporation, announced the acquisition of 100% equity interest in Dongguan Kewei Medical
Dongguan Kewei Medical Instrument Co., Ltd., is a PRC research and development manufacturer of cardiac surgery device oxygenators in extra-corporal circulation and occludes for minimally invasive interventional devices for structural heart diseases. Currently its 14 products have been approved by SFDA. One of its products, KW-membrane oxygenator, was also enrolled into the National Torch Plan as one of the State Key and New Products.
Now, with the completion of this acquisition, MicroPort has officially entered into the field of cardiac surgery. The acquisition not only expanded MicroPort's existing product lineup but also provided MicroPort with significant growth opportunities in the medical device market which in line with the MicroPort's strategic objective.